Irvine Center-Clncl Research Irvine, CA - 92618

Irvine Center-Clncl Research is categorized under Medical Research in Irvine, CA and active since 1978.

Irvine Center-Clncl Research was established in 1978, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Elly Lee, Office Manager at the company’s single location by writing to 16275 Laguna Canyon Road # 100, Irvine, California CA 92618 or by phoning (949) 753-1663. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Irvine Center-Clncl Research
Contact Person: Elly Lee, Office Manager
Address: 16275 Laguna Canyon Road # 100, Irvine, California 92618
Phone Number: (949) 753-1663
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 1978
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Medical Research
SIC Code: 8733
NAICS Code: 6211110
Share This Business:

Irvine Center-Clncl Research was started in 1978 to provide professional Medical Research under the SIC code 8733 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Elly Lee, Office Manager for inquiries that concern Irvine Center-Clncl Research by calling the company number (949) 753-1663, as your correspondence is most welcome. Additionally, the physical location of the single location of Irvine Center-Clncl Research can be found at the coordinates 33.65726,-117.76856 as well as the street address 16275 Laguna Canyon Road # 100 in Irvine, California 92618.

For its online presence, you may visit Irvine Center-Clncl Research’s website at and engage with its social media outlets through on Twitter and on Facebook.